Effect of Exercise on Prevention of Weight Gain
This study has been completed.
Sponsor:
University of Pittsburgh
Collaborator:
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00177502
First received: September 12, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine the dose-response of exercise on prevention of weight gain in overweight adults.
| Condition | Intervention | Phase |
|---|---|---|
|
Weight Loss |
Behavioral: behavioral exercise intervention |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Effect of Exercise on Prevention of Weight Gain |
Resource links provided by NLM:
Further study details as provided by University of Pittsburgh:
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Female or Male
- 18-55 years of age
- BMI = 25-29.9 kg/m2
- Ability to provide informed consent.
- Ability to provide consent from their personal physician to participate in this study.
Exclusion Criteria:
- Reporting regular exercise participation of at least 20 minutes per day on at least 3 days per week during the previous six months. (This study is designed to recruit relatively sedentary adults.)
- Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism.
- Women who are currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 12 months. (Pregnancy during initial screening will be based on self-report and will be included on the detailed medical history that is completed by subjects. However, this will be confirmed with the urine pregnancy test that will be conducted prior to the baseline DEXA.)
- Non-medicated resting systolic blood pressure >160 mmHg or non-medicated resting diastolic blood pressure >100 mmHg, or taking medication that would affect blood pressure.
- Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade).
- Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated.
- History of myocardial infarction or valvular disease.
- History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00177502
Locations
| United States, Pennsylvania | |
| University of Pittsburgh | |
| Pittsburgh, Pennsylvania, United States, 15203 | |
Sponsors and Collaborators
University of Pittsburgh
Investigators
| Principal Investigator: | John M Jakicic, Ph.D. | University of Pittsburgh |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00177502 History of Changes |
| Other Study ID Numbers: | R01 HL070257-01A1, R01 HL070257-01A1 |
| Study First Received: | September 12, 2005 |
| Last Updated: | September 12, 2005 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Weight Gain Weight Loss Body Weight Changes Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 21, 2013